Core Viewpoint - Oruka Therapeutics is actively participating in multiple upcoming conferences to present its advancements in the treatment of chronic skin diseases, particularly plaque psoriasis [1][2]. Group 1: Conference Participation - Oruka will present at the Guggenheim Emerging Outlook: Biotech Summit on February 12, 2026, at 10:30 AM ET [1]. - Additional conferences include the TD Cowen 46 Annual Health Care Conference on March 3, 2026, at 1:10 PM ET, and the UBS Biotech Summit Miami on March 9, 2026 [2]. - Other notable events are the Jefferies Biotech on the Beach Summit on March 10, 2026, the Leerink Global Healthcare Conference on March 11, 2026, at 1:00 PM ET, and the Barclays 28 Annual Global Healthcare Conference on March 12, 2026, at 10:30 AM ET [2]. Group 2: Company Overview - Oruka Therapeutics is focused on developing novel biologics aimed at setting a new standard for treating chronic skin diseases, with a mission to provide patients with significant freedom from conditions like plaque psoriasis [3]. - The company is advancing a proprietary portfolio of potentially best-in-class antibodies engineered by Paragon Therapeutics, targeting the core mechanisms of plaque psoriasis and other dermatologic and inflammatory diseases [3].
Oruka Therapeutics to Participate in Multiple Upcoming Conferences